Emirates Health Services (EHS) has announced the availability of BYANNLI, developed by Johnson & Johnson, for patients with schizophrenia at Al Amal Psychiatric Hospital, one of its affiliated facilities. Al Amal Psychiatric Hospital is the first government hospital in the UAE to introduce this inno. .



